Skip to content

Kiora Pharmaceuticals Inc

KPRX· NasdaqCore metricsCIK 1372514

Pharmaceutical preparations552 peers

Close
Oct 29, 2026
Market cap
$7.79M
4.42M shares
Filings
929
$1.00M
Q3 2026−100.0% FY25 yoy
-$1.75M
Q3 2026N/M FY25 yoy
-$1.69M
Q3 2026N/M FY25 yoy
-$5.64M
Q3 2026derivedN/M FY25 yoy
-$0.28
Q3 2026N/M FY25 yoy
$5.57M
Q3 2026+129.3% FY25 yoy
$7.79M
—
—
0.5×
-129.34%
—

FY2025 figures · derived

Price

$1.7621.78%$0.49past year
Oct 29, 2026 · Official close
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2025
$16.02M0FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$0reported
FY 20242024-12-31$16,020,000reported
FY 20232023-12-31$0reported
FY 20212021-12-31$0reported
FY 20202020-12-31$12,059reported
FY 20192019-12-31$2,686,000reported
FY 20182018-12-31$1,652,520reported
FY 20172017-12-31$407,518reported
FY 20162016-12-31$669,259reported
FY 20152015-12-31$0reported

Pharmaceutical preparations

Kiora Pharmaceuticals Inc is the 429th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Kiora Pharmaceuticals Inc · CIK 1372514 · Engraved from SEC EDGAR